CD4 and myeloid sarcoma: This conclusion is evidenced by genome-wide association studies and analyses of single-nucleotide polymorphisms, which have identified specific alleles related to major histocompatibility complex class II and genes associated with CD4 + T-cell activation as factors in MS development [9, 16].